Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

The Mechanistic Biology of Primary Immunodeficiency Disorders

A legfontosabb adatok

Ki végzi
National Institute of Allergy and Infectious Diseases (NIAID)
Hol
Bethesda és Washington D.C. (Egyesült Államok)Mind a 2 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
1190 fő, tervezett
Kezdés
2018. máj. 30.
Várható befejezés
2040. dec. 31.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A regiszteradat frissítve
2026. november 2.

Ki vehet részt

Életkor
1 nap – 90 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki nem vehet részt

  • Subjects with secondary causes of immunodeficiency are excluded from this study. Secondary causes of immunodeficiency include HIV infection and immunodeficiency that is deemed to be secondary to chronic use of immunosuppressive medications or chemotherapeutic agents
  • Any condition that, in the opinion of the investigator, contraindicates participation in this study

Egyéb feltételek

  • INCLUSION CRITERIA:; Subjects must meet one of the following 3 criteria:
  • Patients (age 0-90 years) with a clinical diagnosis of a form of PID (either known or unknown). PID may be defined by laboratory and/or clinical findings on two or more occasions that are consistent with a defect in innate or adaptive immunity. Specific PIDs are defined by the International Union of Immunological Societies guidelines. These subjects must also be willing to undergo genetic testing and to allow their biospecimens to be modified into iPS cells. Women of childbearing potential, or who are pregnant or lactating, may be eligible, however the volume of blood collected for research purposes will be reduced, and no skin biopsies will be performed for research purposes in consideration of their safety
  • Biological relatives (age 0-90 years) of a subject who meet criterion 1a, but who do not have a PID themselves. Relatives may be mother, father, siblings, children, grandparents, aunts, uncles, and first cousins to a patient. There is no limit due to sex, race, or disability. Women of childbearing potential, or who are pregnant or lactating, may be eligible, however the volume of blood collected for research purposes will be reduced in consideration of their safety. Relatives must also be willing to undergo genetic testing
  • Healthy volunteers (age 18-75 years) who are not related to another study subject, do not have a PID, and meet the following:; Weight greater than 110 pounds; Not have any heart, lung, or kidney disease, or bleeding disorders; Not have a history of viral hepatitis (B or C); Not be infected with HIV; Not be pregnant; All subjects must be willing to allow their samples to be stored for future research

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • National Institutes of Health Clinical CenterBethesda, Egyesült ÁllamokContact: Luigi D Notarangelo, M.D.Résztvevőt keres
  • Children's National Health System (CNHS)Washington D.C., Egyesült ÁllamokContact: Luigi D Notarangelo, M.D.No longer taking part

A vizsgálatról

Mit akar kideríteni a vizsgálat

Background:

A teljes eredeti leírásKevesebb

Primary immunodeficiency disorders, or PIDs, are diseases that weaken the immune system. This makes it easier for a person to get sick. Some PIDs are mild and may not be diagnosed until later in life. Other kinds are severe and can be identified shortly after birth. Researchers want to learn more about PIDs by comparing data from relatives and healthy volunteers to people with a PID.

Objective:

To learn more about PIDs, including their genetic causes.

Eligibility:

People ages 0-90 with a PID or their healthy biological relatives the same ages

Healthy volunteers ages 18-75

Design:

Participants will be screened with a medical history, physical exam, and HIV blood test. They may have a pregnancy test.

Participants may repeat the screening tests.

Blood taken at screening will be used for genetic tests and research tests. Participants will be told test results that affect their health. Some blood will be stored for future research.

Adult participants with a PID may have a small piece of skin removed. The area will be numbed. A small tool will take a piece of skin about the size of a pencil eraser.

Researchers may collect fluid or tissue samples from PID participants regular medical care. They will use them for research tests.

Participants with a PID will have 3 follow-up visits over 10 years (for infants, 2 years). Visits will include a physical exam, medical history, and blood draw.

Participants with a PID and their relatives will be called once a year for 10 years. They will talk about how they are feeling and if they have developed any new symptoms or illnesses.

...

A vizsgálat 3 csoportja

  • Affected Patient

    Person with a clinical diagnosis of a PID (age 0-90); either known or unknown as defined by lab and/or clinical findings on 2 or more occasions that are consistent with a defect in innate or adaptive immunity

  • Normal Volunteer

    Persons (age 18-75 years) who are not related to another study subject, who do not have a PID, weight \>110lbs, no history of viral hepatitis B or C, have a negative HIV screening test

  • Relative of Patient

    Biological relatives (age 0-90 years) of a subject who meets affected patient criteria, but who do not have a PID themselves

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Investigating the Mechanistic Biology of Primary Immunodeficiency Disorders
Publikációk
A regiszteradat frissítve
2026. november 2.